Erucylphosphohomocholine, the first intravenously applicable 
alkylphosphocholine, induces cell cycle arrest, apoptosis, and synergizes with 
chemotherapeutic drugs in acute myelogenous leukemia cells-a novel therapeutic 
approach for leukemia.

Papa, V.; Tazzari, P.; Chiarini, F.; Ricci, F.; Martinelli, G.; Bontadini, A.; McCubrey, J.; Lindner, L. H.; Eibl, H.; Martelli, A. M.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Conference Paper

Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, induces cell cycle arrest, apoptosis, and synergizes with chemotherapeutic drugs in acute myelogenous leukemia cells-a novel therapeutic approach for leukemia.

MPS-Authors

/persons/resource/persons15029

Eibl, H.
Research Group of Phospholipids, MPI for biophysical chemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Papa, V., Tazzari, P., Chiarini, F., Ricci, F., Martinelli, G., Bontadini, A., et al. (2008). Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, induces cell cycle arrest, apoptosis, and synergizes with chemotherapeutic drugs in acute myelogenous leukemia cells-a novel therapeutic approach for leukemia. Blood, 112(11), 480-480.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0012-DA59-E

Abstract

There is no abstract available